FENOFIBRIC ACID DELAYED-RELEASE
These highlights do not include all the information needed to use FENOFIBRIC ACID DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for FENOFIBRIC ACID DELAYED-RELEASE CAPSULES. FENOFIBRIC ACID delayed-release capsule for oral use Initial U.S. Approval: 2008
865b1149-4b66-4150-a023-8448b2c05cd7
HUMAN PRESCRIPTION DRUG LABEL
Dec 5, 2022
Graviti Pharmaceuticals Private Limited
DUNS: 650884781
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
FENOFIBRIC ACID
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (20)
Fenofibric Acid
Product Details
FDA regulatory identification and product classification information